The board of directors of The IBN Sina Pharmaceutical Industry Ltd has recommended 30 per cent cash and 10 per cent stock dividend for the year ended on June 30, 2018, said an official disclosure on Wednesday.
The final approval of dividend will come during the annual general meeting (AGM) scheduled to be held on November 22 in Dhaka.
The record date is October 22, 2018.
The company has also reported earnings per share (EPS) of Tk 15.92, net asset value (NAV) per share of Tk 43.21 and net operating cash flow per share (NOCFPS) of Tk 6.76 for the year ended on June 30, 2018 as against Tk 8.23 (restated), Tk 38.90 (restated) and Tk 4.38 (restated) respectively for the same period of the previous year.
The pharmaceuticals company disbursed 25 per cent cash and 10 per cent stock dividend for the year ended on June 30, 2017.
There will be no price limit on the trading of the shares of the company today following its corporate declaration.
Each share of the company, which was listed on the Dhaka Stock Exchange (DSE) in 1989, closed at Tk 312 on Tuesday, registering an increase of 3.10 per cent over the previous day.
The company’s paid-up capital is Tk 284 million and authorised capital is Tk 500 million, while the total number of securities is 28.40 million.
The sponsor-directors own 44.47 per cent stake in the company, institutional investors 15.16 per cent and the general public 40.37 per cent as on August 31, 2018, the DSE data shows.
